These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 33982651)

  • 1. To Vaccinate or not to Vaccinate; That is the Question! (New Insights into COVID-19 Vaccination).
    El-Nakeep S
    Curr Mol Med; 2022; 22(7):567-571. PubMed ID: 33982651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine.
    Zaprutko T; Kremin Y; Michalak M; Bernatoniene J; Zaprutko L; Hudz N; Stolecka A; Cynar J; Niewczas K; Sprawka J; Skorupska P; Wróbel J; Ratajczak P; Kopciuch D; Paczkowska A; Kus K; Hromovyk B
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of SARS-CoV-2 vaccination resulting from the COVID-19 pandemic with regard to the uptake of influenza virus, pneumococcal, and herpes zoster adult vaccination - a narrative literature review.
    Kłoda K; Mierzecki A; Mastalerz-Migas A; Babicki M
    Ann Agric Environ Med; 2023 Dec; 30(4):587-594. PubMed ID: 38153058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parents' intent to vaccinate against influenza during the COVID-19 pandemic im two regions in Switzerland.
    Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S
    Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 35275392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parents' intent to vaccinate against influenza during the COVID-19 pandemic in two regions in Switzerland.
    Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S; Part Of The International Covid-Parental Attitude Study Covipas Group
    Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 34002802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Virus and SARS-CoV-2 Vaccines.
    Sandor AM; Sturdivant MS; Ting JPY
    J Immunol; 2021 Jun; 206(11):2509-2520. PubMed ID: 34021048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
    Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
    BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans.
    Ferdinand KC; Nedunchezhian S; Reddy TK
    J Natl Med Assoc; 2020 Dec; 112(6):681-687. PubMed ID: 33276969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    Glintborg B; Jensen DV; Terslev L; Hendricks O; Østergaard M; Rasmussen SH; Jensen MP; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Sørensen CM; Krogh NS; Agerbo JN; Ziegler C; Hetland ML
    J Rheumatol; 2022 Oct; 49(10):1163-1172. PubMed ID: 35705237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Palache A; Rockman S; Taylor B; Akcay M; Billington JK; Barbosa P;
    Vaccine; 2021 Oct; 39(41):6081-6087. PubMed ID: 34521551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years.
    Yin JK; Pepin S; van Aalst R; Loiacono MM; Samson SI
    Hum Vaccin Immunother; 2022 Nov; 18(6):2106749. PubMed ID: 35914122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.
    Oberemok VV; Andreeva OA; Laikova KV; Novikov IA; Puzanova YV; Kubyshkin AV
    Inflamm Res; 2022 Jun; 71(5-6):521-536. PubMed ID: 35397666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic.
    Day ME; Klein M; Sucharew H; Carol Burkhardt M; Reyner A; Giles D; Beck AF; Schlaudecker EP
    Vaccine; 2022 Oct; 40(44):6391-6396. PubMed ID: 36182616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Promoting influenza vaccination during 2021-2022 season from the perspective of population medicine].
    Feng LZ; Wang Q; Yang WZ
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3771-3774. PubMed ID: 34895415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].
    Zhang T; Bai XF; Wang W; Liu XX; Zhang XX; Wang DY; Zhang SB; Chen ZP; He HQ; Huang ZY; Xu AQ; Peng ZB; Feng LZ; Yu WZ; Feng Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):103-107. PubMed ID: 34954956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing.
    Song Z; Liu X; Xiang P; Lin Y; Dai L; Guo Y; Liao J; Chen Y; Liang Y; Sun Y
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3337-3346. PubMed ID: 34949917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
    Chen JM; Sun YX; Chen JW
    J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination and COVID-19 infection risk and disease severity: A systematic review and multilevel meta-analysis of prospective studies.
    Del Riccio M; Caini S; Bonaccorsi G; Lorini C; Paget J; van der Velden K; Cosma C
    Am J Infect Control; 2024 Sep; 52(9):1091-1098. PubMed ID: 38768817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.